Our previous study also revealed that the Prevotella-derived metabolite 3-Oxocholic acid significantly increased the expression levels of IL-1β and TNF-α, thus decreasing the efficacy of FOLFOX against CRC in vitro [67]. The gene discussed is TNF; the disease is colorectal carcinoma.